APA (7th ed.) Citation

Jørgensen, C. K., Juul, S., Siddiqui, F., Horowitz, M. A., Moncrieff, J., Munkholm, K., . . . Jakobsen, J. C. (2023). The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: A protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis. Systematic Reviews, 12(1), 1. https://doi.org/10.1186/s13643-023-02221-5

Chicago Style (17th ed.) Citation

Jørgensen, Caroline Kamp, et al. "The Risks of Adverse Events with Venlafaxine and Mirtazapine Versus 'Active Placebo', Placebo, or No Intervention for Adults with Major Depressive Disorder: A Protocol for Two Separate Systematic Reviews with Meta-analysis and Trial Sequential Analysis." Systematic Reviews 12, no. 1 (2023): 1. https://doi.org/10.1186/s13643-023-02221-5.

MLA (9th ed.) Citation

Jørgensen, Caroline Kamp, et al. "The Risks of Adverse Events with Venlafaxine and Mirtazapine Versus 'Active Placebo', Placebo, or No Intervention for Adults with Major Depressive Disorder: A Protocol for Two Separate Systematic Reviews with Meta-analysis and Trial Sequential Analysis." Systematic Reviews, vol. 12, no. 1, 2023, p. 1, https://doi.org/10.1186/s13643-023-02221-5.